Search Results 461-470 of 14974 for alt

1. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

   AST and ALT ≤ 2.5 x ULN; total bilirubin ≤ 1.5 x ULN unless increase is due to Gilbert's disease or similar syndrome involving slow conjugation of ...

2. Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium - Mayo Clinic

   AST and ALT ≤ 50 and total bilirubin levels within normal range. If bilirubin is increased due to a suspected Gilbert's Syndrome, patient may be enrolled ...

3. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

   Serum alanine aminotransferase (ALT) > 2.5× ULN. Positive pregnancy test. The subject has participated in another clinical study involving an IP or ...

4. Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma - Mayo Clinic

   - Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3.0 x ULN - Alkaline (alk) phosphatase (phos) =< 3.0 x ULN - No active, known or ...

5. Clinical Trials - A Study of Outpatients with Cirrhosis

   Platelet count < 150,000 and AST/ALT ratio > 1. Able and willing to provide samples. Specific additional inclusion criteria for the three subgroups ...

6. A Phase 2 Trial Of ALN-APP In Patients With Cerebral Amyloid Angiopathy - Mayo Clinic

   * Has alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \>3×upper limit of normal (ULN) at Screening * Has estimated glomerular filtration ...

7. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

   ALT is normal. Remain on anti-viral therapy, per institutional practice, during the study intervention and follow-up periods to ensure adequate viral ...

8. Losartan for Outpatients on COVID-19 - Clinical Trials

   Documented AST or ALT > 3 times the upper limit of normal within 3 months of randomization (if available in electronic medical record). Potassium > 5.0 mmol ...

9. Clinical Trials - FT576 in Subjects With Multiple Myeloma

   - AST > 3 x ULN or ALT > 3 x ULN, unless directly due to underlying malignancy. - O2 sat < 92% on room air. Clinically significant cardiovascular disease ...

10. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

    Aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) ≤ 2.5x ULN; Alkaline Phosphatase <5x ULN. All females of childbearing potential (not ...